MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0261356
Mebio Labs Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.64 Lakh
▼ 11% YoY
Net profit · FY 2025
₹5.35 Lakh
Net margin 9.8%
EBITDA · FY 2025
₹7.15 Lakh
EBITDA margin 13.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
3
Provident fund records
Directors on board
2
As per MCA filings
About Mebio Labs Private Limited
Data last updated:
Mebio Labs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2015PTC260929. Its GSTIN is 07AAJCM6010A1Z1 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Dazy and Pushkar Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.64 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹5.35 Lakh (net margin 9.8%) and EBITDA of ₹7.15 Lakh (EBITDA margin 13.1%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 15% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 4 cases are pending.
Mebio Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0261356). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mebiolabs.com.
Company Details of Mebio Labs Private Limited
CIN U33110MH2015PTC260929
Registration Number 260929
Incorporation Date 15 January 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0261356
Key People
Dazy Director Pushkar Kumar Director Recognitions & Rankings of Mebio Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressUnit No. 611 Reliable Pride Anand Nagar Opp. Heera Panna Mall Joge, Shwari (W), Mumbai, Maharashtra, India – 400102
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Mebio Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Mebio Labs Private Limited
The main business activity of Mebio Labs is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mebio Labs Private Limited FY 2025 filings available
Mebio Labs Private Limited reported revenue of ₹54.64 Lakh (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹54.64 Lakh ▼ 11%
Net profit · FY 2025
₹5.35 Lakh margin 9.8%
EBITDA · FY 2025
₹7.15 Lakh margin 13.1%
Compounded Annual Growth Rate (CAGR) of Mebio Labs Private Limited
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 14%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 26%
5 years · compounded
▲ 34%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 11% fall in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mebio Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.15 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mebio Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mebio Labs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Mebio Labs Private Limited
Mebio Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dazy | Director | 21 Nov 2022 | 3 Years 11 Months | Current |
| Pushkar Kumar | Director | 15 Jan 2015 | 11 Years 9 Months | Current |
Peer Comparison of Mebio Labs Private Limited
Mebio Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medchem International Limited | ₹54.84 Lakh (FY 2024) | •••• | •••• | -64.0% | •••• | Hyderabad, Telangana, India |
| Hi-Tech Capsules Private Limited | ₹54.79 Lakh (FY 2020) | •••• | •••• | •••• | Panaji, Goa, India | |
| Ameda Pharma Private Limited | ₹54.74 Lakh (FY 2024) | •••• | •••• | 122.0% | •••• | Ahmedabad, Gujarat, India |
| Jagat Kishori Pharmaceuticals Private Limited | ₹54.73 Lakh (FY 2024) | •••• | •••• | 170.0% | •••• | Muzaffarpur, Bihar, India |
| Dazroz Pharmaceuticals Private Limited | ₹54.73 Lakh (FY 2024) | •••• | •••• | 54.0% | •••• | Mumbai, Maharashtra, India |
| Mebio Labs Private Limited this company | ₹54.64 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Mumbai, Maharashtra, India |
| Biostringen Labs Private Limited | ₹54.6 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | New Delhi, Delhi, India |
| Medzelon Pharmaceutical Private Limited | ₹54.59 Lakh (FY 2024) | •••• | •••• | 30.0% | •••• | Kamrup Metropolitan, Assam, India |
| Pious Bioteca Private Limited | ₹54.59 Lakh (FY 2025) | •••• | •••• | 2468.0% | •••• | Ludhiana, Punjab, India |
| Aver Pharmaceuticals Private Limited | ₹54.58 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Gitvin Remedies (GR) Private Limited | ₹54.53 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Mebio Labs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mebio Labs Private Limited
Mebio Labs Private Limited is audited by S C VERMA & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S C VERMA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mebio Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mebio Labs Private Limited
Mebio Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Mebio Labs Private Limited
Mebio Labs Private Limited has 4 court cases on record: 3 filed by Mebio Labs, 1 filed against it. All cases are pending.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 4 |
Cases on record (2 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against M/S Heramba Enterprises | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by an individual | Pending |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Mebio Labs Private Limited
Mebio Labs Private Limited has a workforce of 3 employees as of Apr 06, 2024.
Employee count
3
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mebio Labs Private Limited
Mebio Labs Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Dazy ceased to be Additional Director on 29 Sep 2023.
AGM
Mebio Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mebio Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Dazy ceased to be Additional Director.
Ceased
Mukesh Kumar Verma ceased to be Director.
Appointed
Dazy was appointed as Director.
Ceased
Narendra Yadav ceased to be Director.
Appointed
Pushkar Kumar was appointed as Director.
Incorporation
15 Jan 2015
Mebio Labs Private Limited was registered on 15 Jan 2015 with Roc Mumbai I & aged 11 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Mebio Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mebio Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mebio Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mebio Labs Private Limited
Mebio Labs has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM6010A1Z1 | Delhi | Active | 01 Jul 2017 |
| 08AAJCM6010A1ZZ | Rajasthan | Active | 15 Mar 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mebio Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mebio Labs Private Limited
Mebio Labs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 2015 (11+ years old) and is registered under CIN U33110MH2015PTC260929.
Mebio Labs reported revenue of ₹54.64 Lakh for FY 2025 (down 11% YoY).
Mebio Labs has 2 current directors:
- Dazy - Director
- Pushkar Kumar - Director
Mebio Labs reported a net profit of ₹5.35 Lakh (net margin 9.8%) and EBITDA of ₹7.15 Lakh (EBITDA margin 13.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mebio Labs is -14% over three years and -15% over five years. In the latest year (FY 2025) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mebio Labs is 07AAJCM6010A1Z1, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAJCM6010A1ZZ (Rajasthan).
The CIN (Corporate Identification Number) of Mebio Labs is U33110MH2015PTC260929. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mebio Labs has 4 court cases on record: 3 filed by the company and 1 filed against it. 4 are pending.
Mebio Labs was incorporated on 15 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mebio Labs by revenue are Medchem International Limited, Hi-Tech Capsules Private Limited, Ameda Pharma Private Limited, Jagat Kishori Pharmaceuticals Private Limited, Dazroz Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Dazy ceased to be Additional Director on 29 Sep 2023. Mukesh Kumar Verma ceased to be Director on 24 Nov 2022. Dazy was appointed as Director on 21 Nov 2022. Mebio Labs has 5 board changes on record in total.